All changes for the tissue central nervous system (737)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA162
olfactory receptor, family 2, subfamily H, member 2
Molecular
brain
Human
OR2H2
16.0% Decrease Gene Expression Level
DAA161
oligodendrocyte lineage transcription factor 2
Molecular
brain
Human
OLIG2
12.0% Increase Gene Expression Level
DAA1419
oncostatin M receptor
Molecular
hippocampus
Mouse
Osmr
9.0% Increase Gene Expression Level
DAA159
ornithine decarboxylase antizyme 1
Molecular
brain
Human
OAZ1
4.0% Decrease Gene Expression Level
DAA164
osteoclast stimulating factor 1
Molecular
brain
Human
OSTF1
29.0% Decrease Gene Expression Level
DAA163
oxysterol binding protein
Molecular
brain
Human
OSBP
8.0% Decrease Gene Expression Level
DAA165
p21 protein (Cdc42/Rac)-activated kinase 1
Molecular
brain
Human
PAK1
23.0% Decrease Gene Expression Level
DAA2247
pannexin 1 decreases with age
Molecular
frontal lobe
Human
PANX1
59.9% Decrease Gene Expression Level
DAA2258
pannexin 1 decreases with age
Molecular
parietal lobe
Human
PANX1
50.0% Decrease Gene Expression Level
DAA2268
pannexin 1 decreases with age
Molecular
temporal lobe
Human
PANX1
41.6% Decrease Gene Expression Level
DAA2352
Pannexin 2 decreases with age
Molecular
hippocampus
Human
PANX2
19.1% Decrease Gene Expression Level
DAA2353
Pannexin 2 decreases with age
Molecular
temporal lobe
Human
PANX2
16.5% Decrease Gene Expression Level
DAA2351
Pannexin 2 decreases with age
Molecular
frontal lobe
Human
PANX2
8.1% Decrease Gene Expression Level
DAA614
Parkinson's disease
Pathological
central nervous system
Human
—
SeriesMorbidity
DAA168
PCTAIRE protein kinase 2
Molecular
brain
Human
PCTK2
19.0% Decrease Gene Expression Level
DAA170
PDZ and LIM domain 3
Molecular
brain
Human
PDLIM3
22.0% Increase Gene Expression Level
DAA1422
pellino 1
Molecular
hippocampus
Mouse
Peli1
3.0% Increase Gene Expression Level
DAA1423
peptidoglycan recognition protein 1
Molecular
hippocampus
Mouse
Pglyrp1
8.0% Increase Gene Expression Level
DAA737
Permeability increases with age
Physiological
blood brain barrier
Human
—
—
DAA185
peroxiredoxin 6
Molecular
brain
Human
PRDX6
11.0% Increase Gene Expression Level
DAA175
phosphatidylinositol glycan anchor biosynthesis, class C
Molecular
brain
Human
PIGC
5.0% Decrease Gene Expression Level
DAA176
phosphatidylinositol transfer protein, beta
Molecular
brain
Human
PITPNB
17.0% Decrease Gene Expression Level
DAA169
phosphodiesterase 4D, cAMP-specific (phosphodiesterase E3 dunce homolog, Drosophila)
Molecular
brain
Human
PDE4D
21.0% Decrease Gene Expression Level
DAA177
phospholipase C-like 2
Molecular
brain
Human
PLCL2
10.0% Decrease Gene Expression Level
DAA178
phospholipase D family, member 3
Molecular
brain
Human
PLD3
10.0% Decrease Gene Expression Level
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA162 | olfactory receptor, family 2, subfamily H, member 2 | Molecular | brain | Human | OR2H2 | 16.0% Decrease Gene Expression Level | |
DAA161 | oligodendrocyte lineage transcription factor 2 | Molecular | brain | Human | OLIG2 | 12.0% Increase Gene Expression Level | |
DAA1419 | oncostatin M receptor | Molecular | hippocampus | Mouse | Osmr | 9.0% Increase Gene Expression Level | |
DAA159 | ornithine decarboxylase antizyme 1 | Molecular | brain | Human | OAZ1 | 4.0% Decrease Gene Expression Level | |
DAA164 | osteoclast stimulating factor 1 | Molecular | brain | Human | OSTF1 | 29.0% Decrease Gene Expression Level | |
DAA163 | oxysterol binding protein | Molecular | brain | Human | OSBP | 8.0% Decrease Gene Expression Level | |
DAA165 | p21 protein (Cdc42/Rac)-activated kinase 1 | Molecular | brain | Human | PAK1 | 23.0% Decrease Gene Expression Level | |
DAA2247 | pannexin 1 decreases with age | Molecular | frontal lobe | Human | PANX1 | 59.9% Decrease Gene Expression Level | |
DAA2258 | pannexin 1 decreases with age | Molecular | parietal lobe | Human | PANX1 | 50.0% Decrease Gene Expression Level | |
DAA2268 | pannexin 1 decreases with age | Molecular | temporal lobe | Human | PANX1 | 41.6% Decrease Gene Expression Level | |
DAA2352 | Pannexin 2 decreases with age | Molecular | hippocampus | Human | PANX2 | 19.1% Decrease Gene Expression Level | |
DAA2353 | Pannexin 2 decreases with age | Molecular | temporal lobe | Human | PANX2 | 16.5% Decrease Gene Expression Level | |
DAA2351 | Pannexin 2 decreases with age | Molecular | frontal lobe | Human | PANX2 | 8.1% Decrease Gene Expression Level | |
DAA614 | Parkinson's disease | Pathological | central nervous system | Human | — | SeriesMorbidity | |
DAA168 | PCTAIRE protein kinase 2 | Molecular | brain | Human | PCTK2 | 19.0% Decrease Gene Expression Level | |
DAA170 | PDZ and LIM domain 3 | Molecular | brain | Human | PDLIM3 | 22.0% Increase Gene Expression Level | |
DAA1422 | pellino 1 | Molecular | hippocampus | Mouse | Peli1 | 3.0% Increase Gene Expression Level | |
DAA1423 | peptidoglycan recognition protein 1 | Molecular | hippocampus | Mouse | Pglyrp1 | 8.0% Increase Gene Expression Level | |
DAA737 | Permeability increases with age | Physiological | blood brain barrier | Human | — | — | |
DAA185 | peroxiredoxin 6 | Molecular | brain | Human | PRDX6 | 11.0% Increase Gene Expression Level | |
DAA175 | phosphatidylinositol glycan anchor biosynthesis, class C | Molecular | brain | Human | PIGC | 5.0% Decrease Gene Expression Level | |
DAA176 | phosphatidylinositol transfer protein, beta | Molecular | brain | Human | PITPNB | 17.0% Decrease Gene Expression Level | |
DAA169 | phosphodiesterase 4D, cAMP-specific (phosphodiesterase E3 dunce homolog, Drosophila) | Molecular | brain | Human | PDE4D | 21.0% Decrease Gene Expression Level | |
DAA177 | phospholipase C-like 2 | Molecular | brain | Human | PLCL2 | 10.0% Decrease Gene Expression Level | |
DAA178 | phospholipase D family, member 3 | Molecular | brain | Human | PLD3 | 10.0% Decrease Gene Expression Level |